Rebecca Lin
Direktor/Vorstandsmitglied bei Shanghai Rarestone Health Tech Group Co. Ltd.
Aktive Positionen von Rebecca Lin
| Unternehmen | Position | Beginn | Ende |
|---|---|---|---|
| Eight Roads Capital Advisors (CHINA) | Private Equity Investor | 01.01.2021 | - |
Shanghai Rarestone Health Tech Group Co. Ltd.
 Shanghai Rarestone Health Tech Group Co. Ltd. Pharmaceuticals: MajorHealth Technology Shanghai Rarestone Health Tech Group Co. Ltd. is a Chinese company that focuses on rare disease therapy and self-management information through internet information. The company is based in Huangpu, China. The company also operates and promote medical devices and communication platforms. The CEO of the company is Shawn Xiang. | Direktor/Vorstandsmitglied | - | - |
Karriereverlauf von Rebecca Lin
Ausbildung von Rebecca Lin
| Shenzhen University | Undergraduate Degree |
| The Wharton School of the University of Pennsylvania | Masters Business Admin |
Statistik
International
| China | 4 |
| Vereinigte Staaten | 2 |
Operativ
| Private Equity Investor | 1 |
| Director/Board Member | 1 |
| Undergraduate Degree | 1 |
Sektoral
| Consumer Services | 3 |
| Finance | 2 |
| Health Technology | 2 |
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Unternehmensverbindungen
| Private Unternehmen | 2 |
|---|---|
| Eight Roads Capital Advisors (CHINA) | Finance |
Shanghai Rarestone Health Tech Group Co. Ltd.
Shanghai Rarestone Health Tech Group Co. Ltd. Pharmaceuticals: MajorHealth Technology Shanghai Rarestone Health Tech Group Co. Ltd. is a Chinese company that focuses on rare disease therapy and self-management information through internet information. The company is based in Huangpu, China. The company also operates and promote medical devices and communication platforms. The CEO of the company is Shawn Xiang. | Health Technology |
- Börse
- Insiders
- Rebecca Lin
- Erfahrung
